420122-71-0

Upstream product

• 420122-70-9 5'-azido-N⁶-benzoyl-3'-(tert-butyloxycarbonylamino)-2'-O-(tert-butyldimethylsilyl)-3',5'-dideoxyadenosine 
• 65109-11-7 2',5'-bis-O-(tert-butyldimethylsilyl)adenosine 
• 86734-95-4 9-(2,5-di-O-tert-butyldimethylsilyl-β-D-erythro-pentofuran-3-ulosyl)adenosine 
• 125127-12-0 (3aR,4S,6R,6aR)-6-(6-amino-9H-purin-9-yl)-3-benzyl-4-((tert-butyldiphenylsilyloxy)methyl)tetrahydrofuro[3,4-d]oxazol-2(3H)-one 
• 125084-69-7 9-<2-O-<(benzylamino)carbonyl>-3-bromo-5-O-<(tert-butyl)diphenylsilyl>-3-deoxy-β-D-xylofuranosyl>adenine 
• 125084-68-6 9-<3-bromo-5-O-<(tert-butyl)diphenylsilyl>-3-deoxy-β-D-xylofuranosyl>adenine 
• 557771-59-2 (2R,3S,4S,5R)-2-(6-amino-9H-purin-9-yl)-4-bromo-5-((tert-butyldiphenylsilyloxy)methyl)tetrahydrofuran-3-yl acetate 
• 119898-65-6 (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-((tert-butyldiphenylsilyloxy)methyl)tetrahydrofuran-3,4-diol 
• 58-61-7 adenosine 
• 420122-68-5 2'-O-(tert-butyldimethylsilyl)-3'-(hydroxyamino)-3'-deoxyadenosine 
• 420123-08-6 N⁶-benzoyl-3'-(tert-butyloxycarbonylamino)-2'-O-(tert-butyldimethylsilyl)-3'-deoxyadenosine 
• 420122-69-6 3'-(tert-butyloxycarbonylamino)-2'-O-(tert-butyldimethylsilyl)-3'-deoxyadenosine 

Downstream Products

• 420122-75-4 N⁶-benzoyl-2'-O-(tert-butyldimethylsilyl)-3'-[(N-(9-fluorenylmethyloxycarbonyl)thiocarbamoyl)amino]-5'-(4-monomethoxytritylamino)-3',5'-dideoxyadenosine 
• 420122-73-2 N⁶-benzoyl-2'-O-(tert-butyldimethylsilyl)-3'-(9-fluorenylmethyloxycarbonylamino)-5'-(4-monomethoxytritylamino)-3',5'-dideoxyadenosine 
• 420122-74-3 3'-amino-N⁶-benzoyl-2'-O-(tert-butyldimethylsilyl)-5'-(4-monomethoxytritylamino)-3',5'-dideoxyadenosine 
• 420122-72-1 5'-azido-N⁶-benzoyl-2'-O-(tert-butyldimethylsilyl)-3'-(9-fluorenylmethyloxycarbonylamino)-3',5'-dideoxyadenosine 

Relevant academic research and scientific papers

CYCLIC DINUCLEOTIDE ANALOGS FOR TREATING CONDITIONS ASSOCIATED WITH STING (STIMULATOR OF INTERFERON GENES) ACTIVITY

This disclosure features chemical entities (e.g., a compound that modulates (e.g., agonizes or partially agonizes) Stimulator of Interferon Genes (STING), or a pharmaceutically acceptable salt, and/or hydrate, and/or cocrystal, and/or drug combination of

Synthesis of ribonucleic guanidine: Replacement of the negative phosphodiester linkages of RNA with positive guanidinium linkages

Replacement of the negatively charged phosphodiester linkages of RNA with positively charged guanidinium linkages provides the polycationic ribonucleic guanidine (RNG). RNG is designed to bind strongly to target DNA/RNA through the specific interactions o